This retrospective study assessed the serum IgG antibody response to different MOG isoforms, as well as the value of using additional MOG isoforms on MOG-IgG in cell based assays.
Your search for major depressive disorder returned 17 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
While neurological and psychiatric sequelae of COVID-19 have been reported, more data are needed to adequately assess the effects of COVID-19 on brain health.
This study highlights the importance of transdiagnostic approaches to psychiatry.
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.
Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient’s specific challenges.
A study of Chinese healthcare workers may foreshadow the mental health burden placed upon physicians, nurses, and other professionals as COVID-19 strains the medical system in the United States.
The clinical approach to management of Cushing disease is often complex and education on a clear approach is paramount.
When combined with other serotonergic agents, selective serotonin reuptake inhibitors can lead to a potentially fatal condition called serotonin syndrome, the incidence of which is likely underestimated.
Perhaps it is that tension between undeniable differences and inevitable merging that has led to more recent calls for cross-disciplinary cooperation.
Investigators sought to determine how prevalent and severe intractable nausea, vomiting, or hiccups are in patients with AQP4-IgG-positive NMOSD.
The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.
Delay or lack of speech, seizures, and walking/balance disorders are some of the symptoms associated with AS.
For patients with major depressive disorde, relapse is associated with brain cortical changes over two years.
While the optimal depression screening timing and interval remains unknown, the USPSTF suggests screening all adults, regardless of risk factors, who have not been screened previously.